Regeneron Pharmaceuticals, Inc. (REGN) Ownership

$716.26

south_east
-$0 (0%)
Day's range
$715
Day's range
$716.26

Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 9.29 M $6.61 B   -0.36% 8.59%
BLACKROCK FUNDING, INC. /DE 02/07/2025 8.73 M $6.22 B   2.96% 8.11%
FMR LLC 02/13/2025 8.20 M $5.84 B   -20.87% 7.59%
JPMORGAN CHASE & CO 02/12/2025 7.06 M $5.03 B   -5.74% 6.53%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 4.74 M $3.37 B   41.55% 4.40%
CAPITAL WORLD INVESTORS 02/13/2025 2.78 M $1.98 B   -35.35% 2.58%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.43 M $1.73 B   6.84% 2.25%
DODGE & COX 02/13/2025 2.32 M $1.65 B   0.41% 2.16%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 2.09 M $1.49 B   63.53% 1.93%
FRANKLIN RESOURCES INC 02/12/2025 2.05 M $1.46 B   7.86% 1.90%
LOOMIS SAYLES & CO L P 02/12/2025 1.58 M $1.12 B   33.35% 1.46%
AMUNDI 02/07/2025 1.55 M $1.14 B   45.81% 1.44%
NORGES BANK 02/12/2025 1.13 M $802.04 M   100.00% 1.04%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 982,064 $699.55 M   30.06% 0.91%
INVESCO LTD. 02/13/2025 864,249 $615.63 M   -25.57% 0.80%
LEGAL & GENERAL GROUP PLC 02/13/2025 777,477 $553.82 M   -18.94% 0.72%
AMERICAN CENTURY COMPANIES INC 02/11/2025 707,546 $504.01 M   -4.19% 0.66%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 695,799 $495.64 M   3.35% 0.64%
BANK OF NEW YORK MELLON CORP 02/04/2025 689,263 $490.98 M   -3.61% 0.64%
GOLDMAN SACHS GROUP INC 02/11/2025 644,637 $459.19 M   5.84% 0.60%
ALLIANCEBERNSTEIN L.P. 02/12/2025 623,156 $443.89 M   7.53% 0.58%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 587,025 $418.11 M   2.98% 0.54%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 539,596 $384.37 M   82.66% 0.50%
DEUTSCHE BANK AG\ 02/14/2025 539,269 $384.14 M   21.75% 0.50%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/12/2025 511,556 $364.40 M   5.29% 0.48%
D. E. SHAW & CO., INC. 02/14/2025 500,230 $356.33 M   87.89% 0.46%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 475,630 $338.81 M   -30.73% 0.44%
NEUBERGER BERMAN GROUP LLC 02/13/2025 462,529 $329.47 M   2.88% 0.43%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 441,654 $314.60 M   190.62% 0.41%
HSBC HOLDINGS PLC 02/14/2025 433,804 $308.59 M   21.49% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 393,500 $280.30 M   -21.32% 0.36%
BARCLAYS PLC 02/13/2025 385,178 $274.38 M   -6.68% 0.36%
UBS GROUP AG 02/14/2025 382,835 $272.70 M   40.83% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 371,900 $264.92 M   24.30% 0.34%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 02/12/2025 363,496 $258.93 M   -2.19% 0.34%
TD ASSET MANAGEMENT INC 02/11/2025 359,389 $256.00 M   8.88% 0.33%
GOLDMAN SACHS GROUP INC 02/11/2025 360,400 $256.72 M   24.97% 0.33%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 356,410 $253.88 M   5.43% 0.33%
AMERIPRISE FINANCIAL INC 02/14/2025 326,551 $232.40 M   -10.96% 0.30%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 02/14/2025 310,153 $220.93 M   59.36% 0.29%
SWISS NATIONAL BANK 02/10/2025 306,300 $218.19 M   -4.76% 0.28%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/28/2025 302,616 $215.56 M   0.37% 0.28%
ROYAL BANK OF CANADA 02/14/2025 288,937 $205.82 M   10.52% 0.27%
FIRST TRUST ADVISORS LP 02/13/2025 272,592 $194.18 M   -6.63% 0.25%
CANDRIAM S.C.A. 02/07/2025 261,498 $186.27 M   3.55% 0.24%
SQUAREPOINT OPS LLC 02/14/2025 254,579 $181.34 M   519.41% 0.24%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 247,743 $176.47 M   17.18% 0.23%
CANADA PENSION PLAN INVESTMENT BOARD 02/13/2025 243,473 $173.43 M   65.79% 0.23%
NATIONAL PENSION SERVICE 02/05/2025 232,450 $165.58 M   3.95% 0.22%
CHEVY CHASE TRUST HOLDINGS, LLC 01/30/2025 229,767 $163.67 M   -3.61% 0.21%

Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 1833 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 9.29 M

BlackRock Funding, Inc. /DE: 8.73 M

FMR LLC: 8.2 M

JPMORGAN CHASE & CO: 7.06 M

Capital International Investors: 4.74 M

Capital World Investors: 2.78 M

86.36% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 112.65 M shares in the last 24 months. This purchase volume represents approximately $80.69 B in transactions.